About

Who we are

Discover more

BigHat colleagues in a meeting room overlooking trees, one pointing to a screen

We are an interdisciplinary team of experts in AI and drug discovery and development, supported by experienced leaders, world-class advisors, and top-notch investors.

Overview

85

+

Employees

$

223

M

Funding

Clinical Stage

Biotech

Who we are

Experts in AI and Drug Discovery

Drug Development

Antibody Discovery and Engineering
Multi-parameter optimization
From Target to Clinic

Technology

Frontier intelligence
ML-native stack
High-throughput automation

Biology

Synthetic Biology
Genetics
Molecular Biology

Meet the team

We are a team of scientists, seasoned engineers, and problem solvers leveraging frontier AI to develop transformative, next-generation therapeutics for patients.

Chief Information Officer

Chief Development Officer

VP, Machine Learning

Peyton Greenside

CEO & Co-Founder

VP, Discovery Medicine

Liz Schwarzbach

Chief Business Officer

Chief Scientific Officer

Brett Weinstein

Principal Scientist, Biomolecular Characterization

Snigdha Agarwal

Software Engineer II

Research Associate II, CFPS Production

Senior Software Engineer II

Sr. Software Engineer II

Senior Director, Partnering and Strategy

Assistant Lab Manager

Danielle Barreras

Associate Scientist

Nicholas Bhattacharya

Machine Learning Scientist II

Principal Software Engineer, Data Ops

Associate Scientist

Principal Automation Engineer

Associate Director, Discovery Medicine

Associate Director, Cell-Free Production

Sr. Scientist II, CFPS Development

Senior Data Scientist I

Associate Scientist

Sr. Executive Administrator

Associate Director, External Programs

Associate Scientist

Senior Scientist, Display Technologies

Associate Director, People Operations

Director, Engineering

Crystal Humphries

Principal Data Scientist

Director, Discovery Medicine

Sr. Scientist I, Translational Research

Director, Alliance Management

Scientist I, Discovery Medicine

Sr. Automation Engineer I

Anisha Keshavan

Principal Data Scientist

Senior Research Associate

Software Engineer

Associate Scientist

Sr. Software Engineer I

Sr. Research Associate

Phil Maffettone

Sr Machine Learning Scientist II

Senior Scientist I, Cell Line Engineering

Sr. Lab Manager

Monique Merchant

Scientist II, Discovery Medicine

Director, Protein Sciences

Melanie Montgomery

Sr. Scientist II

Brendan Mullaney

Sr. Director, Scientific Software Product

Research Associate II

Research Associate I

Sr Machine Learning Scientist II

Ing Ongpipattanakul

Scientist II, External Programs

Principal Research Associate

Lindsey Osimiri

Sr. Manager, Data Science

Associate Director, In Vivo Operations

Lab Operations Associate

Sr Director, Development Program Management

Director, Engineering

Research Associate I

Sr. Software Engineer II

Annalisa Sharkey

Product Manager II

Senior Director, Corporate Operations

Sr. Scientist I

Associate Director, Computational Platform

Katrina Stephenson

Sr. Scientist I

Barbara Steurer

Sr. Scientist I, Target Biology

Sr. Automation Engineer II

Jordan Sullivan

Associate Director, Production and Reagents

Elisabeth Visser

Sr. Research Associate

Business Operations Specialist

Sr. Director, Preclinical Development

Michael Yessaillian

Sr. Software Engineer I

Senior Director, Antibody Engineering

Vineeta Agarwala, MD PhD

General Partner, a16z

Founder and former CEO and Executive Chairman of Verily

Francisco Gimenez, PhD

Peyton Greenside

CEO & Co-Founder

Partner, DFJ Growth

Marc Martin-Casas

Vice President of Biotech and Healthcare, Premji Invest

Steve Doberstein, PhD

Jacob Gardner, PhD

Andrew Gordon Wilson, PhD

Michael Jewett, PhD

Brian Kobilka, MD

Stanley Lapidus

Nigel Reuel, PhD

Theresa Tribble

Investors

World-class investors

Awards & Recognition

Global recognition & industry awards

BioSpace's 2025 "40 Under 40" — Peyton Greenside, CEO & Co-Founder, named an honoree in the inaugural class

The Healthcare Technology Report's Top 25 Biotech and Life Sciences Companies of 2025 — BigHat ranked #17

BigHat named to Fierce Biotech's 2024 Fierce 15

BigHat featured on Genetic Engineering and Biotechnology News

BigHat featured on Genetic Engineering & Biotechnology News

BigHat makes Business Insider's 2023 most promising Generative AI Startup list picked by top VCs

BigHat's CSO featured on Bay Area's next generation of life science researchers on San Francisco Business Times

BigHat's CSO, Peyton Greenside Wins Biocom Life Science Catalyst Award

UCSF Digital Health Award

"Therapeutics Innovation of the Year” from BioTech Breakthrough

BigHat in Pharma’s Almanac Q1 2022 Issue

Business Insider’s top 24 Biotech startups by leading VCs

CSO awarded Women of Influence Award by SVBJ

Amgen’ Golden Ticket

PARTNER

Partner with us

BigHat is defining what AI and gold-standard data can do for antibody therapeutics.

Find out more